Ozempic and Wegovy, once Europe’s crown jewels, now facing their demons

BAGSVAERD, DENMARK – Copycat drugs, tariffs, US competitors, and insurance coverage headaches are throwing off a once-thriving EU weight-loss market and its Danish crown jewel, Novo Nordisk.  

In early May, Novo Nordisk’s CEO, Lars…